Physician profile
Robin E Cartwright
NPI 1700113875
$2,913.01
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $493 · 2022: $1,230 · 2023: $1,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,101 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.27 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $970.27 | 2021-2023 | Brilinta, Farxiga |
| Amgen INC. | $578.75 | 2021-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $282.92 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $223.82 | 2021-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $166.96 | 2021-2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $150.93 | 2021-2023 | Camzyos |
| Actelion Pharmaceuticals US, INC. | $108.41 | 2022-2023 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.01 | 2023 | Lifevest |
| Pfizer INC. | $70.88 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.96 | 2022-2023 | |
| Inspire Medical Systems, INC. | $35.14 | 2023 | Inspire |
| Amarin Pharma, INC. | $30.91 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $30.28 | 2023 | Inpefa |
| Abbott Laboratories | $29.39 | 2022 | |
| Sanofi-Aventis U.S. LLC | $21.22 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $21.13 | 2023 | Injectafer |
| Janssen Pharmaceuticals, INC | $19.57 | 2022 | |
| Esperion Therapeutics, INC. | $18.17 | 2021 | |
| Impulse Dynamics (USA) INC. | $12.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Cartwright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.